000566 Stock Overview
Manufactures and sells pharmaceutical products and medical devices in China and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Hainan Haiyao Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥5.07 |
| 52 Week High | CN¥7.11 |
| 52 Week Low | CN¥2.83 |
| Beta | 0.47 |
| 11 Month Change | 1.00% |
| 3 Month Change | 66.78% |
| 1 Year Change | 3.26% |
| 33 Year Change | 11.18% |
| 5 Year Change | -11.05% |
| Change since IPO | -62.11% |
Recent News & Updates
Recent updates
Shareholder Returns
| 000566 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | -4.7% | -0.6% | -2.8% |
| 1Y | 3.3% | -8.7% | 2.0% |
Return vs Industry: 000566 exceeded the CN Pharmaceuticals industry which returned -7.9% over the past year.
Return vs Market: 000566 matched the CN Market which returned 3.2% over the past year.
Price Volatility
| 000566 volatility | |
|---|---|
| 000566 Average Weekly Movement | 13.8% |
| Pharmaceuticals Industry Average Movement | 7.4% |
| Market Average Movement | 8.4% |
| 10% most volatile stocks in CN Market | 12.7% |
| 10% least volatile stocks in CN Market | 5.6% |
Stable Share Price: 000566's share price has been volatile over the past 3 months compared to the CN market.
Volatility Over Time: 000566's weekly volatility has increased from 8% to 14% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1965 | 2,108 | Junhong Wang | www.haiyao.com.cn |
Hainan Haiyao Co., Ltd. manufactures and sells pharmaceutical products and medical devices in China and internationally. The company develops intermediates, APIs, innovative chemical drugs, modern Chinese medicines, biological drugs, cellular immunity products, and high-end medical devices. It offers its products in various forms, such as pills, tablet granules, tincture fluid extracts, powders, syrups, soft capsule raw materials, powder injections, and health foods in various antibiotic series, gastrointestinal medication series, anti-tumor medicine series, cochlear implant series, etc.; and vitamin C for injection scurvy, idiopathic methemoglobinemia, etc. The company also provides internet medical treatment and medical services.
Hainan Haiyao Co., Ltd. Fundamentals Summary
| 000566 fundamental statistics | |
|---|---|
| Market cap | CN¥6.58b |
| Earnings (TTM) | -CN¥377.13m |
| Revenue (TTM) | CN¥1.03b |
6.4x
P/S Ratio-17.4x
P/E RatioIs 000566 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 000566 income statement (TTM) | |
|---|---|
| Revenue | CN¥1.03b |
| Cost of Revenue | CN¥638.68m |
| Gross Profit | CN¥391.97m |
| Other Expenses | CN¥769.11m |
| Earnings | -CN¥377.13m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.29 |
| Gross Margin | 38.03% |
| Net Profit Margin | -36.59% |
| Debt/Equity Ratio | 226.0% |
How did 000566 perform over the long term?
See historical performance and comparison